Tinlarebant
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Tinlarebant, covering 2024-04-12 to 2026-03-12. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2/3 Study to Evaluate the Efficacy and Safety of Tinlarebant in Subjects With Stargardt Disease [Phase 2, Phase 3]